No insider-trading filing for this company in the last two years.
| Filed | Acquirer | Direction | Mode | Acquired | Sold | Holding after | Promoter |
|---|---|---|---|---|---|---|---|
| 18 Jun 2025 | OrbiMed Asia IV Mauritius FVCI Limited Reg29(2) |
Sale | Others | — | 10,273,443 2.27% |
8.62% | No |
| 20 Mar 2023 | Mrs. Sandra Saldanha alongwith PAC Reg29(2) |
Acquisition | Others | — | — | 0.05% | Yes |
| 3 Mar 2023 | Mrs. Sandra Saldanha alongwith PAC Reg29(2) |
Acquisition | Others | 75,000 0.02% |
— | 0.02% | Yes |
| 31 Jan 2023 | OrbiMed Asia IV Mauritius FVCI Limited Reg29(1) |
Acquisition | Others | 49,324,324 10.88% |
— | 12.05% | No |
| 31 Jan 2023 | Mark Saldanha Reg29(2) |
Acquisition | Others | 1,000,000 0.22% |
— | 43.80% | Yes |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
